HIGHLIGHTS
- who: Prognostic et al. from the Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan, China have published the article: A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2), in the Journal: (JOURNAL)
- what: This study analyzed the correlation of STC2 expression with clinicopathology.
- how: The results indicated that the screening result of the differential analysis was stable and reliable in the present study. The results showed that high expression levels of STC2 were associated with poorer OS in BLCA COAD ESCA HNSC kidney renal papillary cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.